P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel (Q40742310)
Jump to navigation
Jump to search
scientific article published on February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel |
scientific article published on February 2002 |
Statements
1 reference
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel (English)
1 reference
Yoshimitsu Kimura
1 reference
Jun Aoki
1 reference
Masayuki Kohno
1 reference
Hisayoshi Ooka
1 reference
Takashi Tsuruo
1 reference
Osamu Nakanishi
1 reference
1 February 2002
1 reference
1 reference
49
1 reference
4
1 reference
322-328
1 reference
Identifiers
1 reference
1 reference